UK markets close in 4 hours 45 minutes

GenSight Biologics S.A. (GSGTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
4.75000.0000 (0.00%)
At close: 10:32AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 214.72M
Enterprise value 172.33M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)19.76
Price/book (mrq)6.19
Enterprise value/revenue 32.66
Enterprise value/EBITDA -6.75

Trading information

Stock price history

Beta (5Y monthly) 2.61
52-week change 3-57.96%
S&P500 52-week change 3-2.90%
52-week high 311.3000
52-week low 34.5000
50-day moving average 34.7500
200-day moving average 36.5801

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 545.2M
Implied shares outstanding 6N/A
Float 827.82M
% held by insiders 114.91%
% held by institutions 137.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin 0.00%
Operating margin (ttm)-364.93%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)7.7M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)-80.30%
Gross profit (ttm)7.7M
EBITDA -27.79M
Net income avi to common (ttm)-28.6M
Diluted EPS (ttm)-0.6580
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)0.72

Cash flow statement

Operating cash flow (ttm)-17.1M
Levered free cash flow (ttm)N/A